These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 11774116

  • 21. Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients.
    Carrasco MN, Bueno A, de las Cuevas C, Jimenez S, Salinas I, Sartorius A, Recio T, Generelo M, Ruiz-Ocaña F.
    Intensive Care Med; 2004 Apr; 30(4):633-8. PubMed ID: 14722639
    [Abstract] [Full Text] [Related]

  • 22. Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis.
    Finkelstein ES, Jekel J, Troidle L, Gorban-Brennan N, Finkelstein FO, Bia FJ.
    Am J Kidney Dis; 2002 Jun; 39(6):1278-86. PubMed ID: 12046042
    [Abstract] [Full Text] [Related]

  • 23. Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study.
    Camargo LF, Marra AR, Büchele GL, Sogayar AM, Cal RG, de Sousa JM, Silva E, Knobel E, Edmond MB.
    J Hosp Infect; 2009 Jul; 72(3):227-33. PubMed ID: 19443078
    [Abstract] [Full Text] [Related]

  • 24. In vivo efficacy of antimicrobial-coated fabric from prosthetic heart valve sewing rings.
    Darouiche RO, Meade R, Mansouri M, Raad II.
    J Heart Valve Dis; 1998 Nov; 7(6):639-46. PubMed ID: 9870198
    [Abstract] [Full Text] [Related]

  • 25. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K, Lam TB.
    Neurourol Urodyn; 2008 Nov; 27(8):738-46. PubMed ID: 18951451
    [Abstract] [Full Text] [Related]

  • 26. In vitro evaluation of the antimicrobial efficacy of a new silver-triclosan vs a silver collagen-coated polyester vascular graft against methicillin-resistant Staphylococcus aureus.
    Ricco JB, Assadian A, Schneider F, Assadian O.
    J Vasc Surg; 2012 Mar; 55(3):823-9. PubMed ID: 22079169
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients.
    Sheng WH, Ko WJ, Wang JT, Chang SC, Hsueh PR, Luh KT.
    Diagn Microbiol Infect Dis; 2000 Sep; 38(1):1-5. PubMed ID: 11025176
    [Abstract] [Full Text] [Related]

  • 28. The effectiveness of chlorhexidine-silver sulfadiazine impregnated central venous catheters in patients receiving high-dose chemotherapy followed by peripheral stem cell transplantation.
    Maaskant JM, De Boer JP, Dalesio O, Holtkamp MJ, Lucas C.
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):477-82. PubMed ID: 19453696
    [Abstract] [Full Text] [Related]

  • 29. A new catheter to prevent exit-site infection in peritoneal dialysis.
    Catizone L, Cantaluppi A, Peluso F, Zucchelli P.
    Adv Perit Dial; 1992 Sep; 8():283-7. PubMed ID: 1361806
    [Abstract] [Full Text] [Related]

  • 30. An animal study of a newly developed skin-penetrating pad and covering material for catheters to prevent exit-site infection in continuous ambulatory peritoneal dialysis.
    Aoyama M, Mizuno T, Tatsumi E, Taenaka Y, Nemoto Y, Okamoto Y, Takemoto Y, Naganuma T, Nakatani T.
    Artif Organs; 2009 Dec; 33(12):1127-33. PubMed ID: 19604229
    [Abstract] [Full Text] [Related]

  • 31. Emergence of resistance in staphylococci after long-term mupirocin application in patients on continuous ambulatory peritoneal dialysis.
    Cavdar C, Atay T, Zeybel M, Celik A, Ozder A, Yildiz S, Gulay Z, Camsari T.
    Adv Perit Dial; 2004 Dec; 20():67-70. PubMed ID: 15384798
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Development of an infection-resistant LVAD driveline: a novel approach to the prevention of device-related infections.
    Choi L, Choudhri AF, Pillarisetty VG, Sampath LA, Caraos L, Brunnert SR, Oz MC, Modak SM.
    J Heart Lung Transplant; 1999 Nov; 18(11):1103-10. PubMed ID: 10598734
    [Abstract] [Full Text] [Related]

  • 36. Frequency of various types of peritoneal catheter infections and therapeutic outcome of treatment.
    Gucek A, Benedik M, Zakelj B, Stanisavljevic D, Lindic J, Hergouth V, Bren AF.
    Adv Perit Dial; 1995 Nov; 11():149-51. PubMed ID: 8534690
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin.
    Raad I, Darouiche R, Hachem R, Mansouri M, Bodey GP.
    J Infect Dis; 1996 Feb; 173(2):418-24. PubMed ID: 8568304
    [Abstract] [Full Text] [Related]

  • 39. Silver iontophoretic catheter: a prototype of a long-term antiinfective vascular access device.
    Raad I, Hachem R, Zermeno A, Stephens LC, Bodey GP.
    J Infect Dis; 1996 Feb; 173(2):495-8. PubMed ID: 8568321
    [Abstract] [Full Text] [Related]

  • 40. Complications of continuous ambulatory peritoneal dialysis.
    Stuart S, Booth TC, Cash CJ, Hameeduddin A, Goode JA, Harvey C, Malhotra A.
    Radiographics; 2009 Feb; 29(2):441-60. PubMed ID: 19325058
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.